Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

The study found that treatment improved hair condition in patients with Fibrosing Alopecia in a Pattern Distribution in Chile.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Only 22% of teenage girls in the study knew about PCOS, despite many having symptoms.

Eating less and exercising more, with personalized diet plans and realistic goals, can lead to weight loss and better health, but more research is needed for long-term success.

Doxazosin and finasteride negatively affect sexual function in men with BPH.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

A patient with Werner syndrome showed a range of aging-like symptoms and metabolic issues, underscoring the need for early detection and treatment.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Men with severe early-onset baldness may have worse heart artery function and stiffer arteries if they have high blood pressure.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Skin problems can indicate different diseases inside the body.

Dialysis patients benefit from water-soluble vitamins but need careful management to avoid risks.

Traditional Chinese Medicine and acupuncture may improve Polycystic Ovarian Syndrome symptoms and reduce costs, but more research is needed.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

About 15% of adolescent girls in a region of India have Polycystic Ovarian Syndrome, which is more common in those born by cesarean, with wisdom teeth, or with central obesity.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

Female pattern hair loss affects 32.3% of women, increasing with age and showing no racial differences.